These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36066666)
41. STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis. Ye Z; Lu X; Zhu M; Bi L; Yang F; Zhou B; Xu D; Yao L Mol Pharm; 2024 Jun; 21(6):2865-2877. PubMed ID: 38666508 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer. Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647 [TBL] [Abstract][Full Text] [Related]
43. PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN. Pan D; Yan Y; Yang R; Xu YP; Chen F; Wang L; Luo S; Yang M Contrast Media Mol Imaging; 2014; 9(5):342-8. PubMed ID: 24729577 [TBL] [Abstract][Full Text] [Related]
44. Development of Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889 [TBL] [Abstract][Full Text] [Related]
45. A novel facile method of labeling octreotide with (18)F-fluorine. Laverman P; McBride WJ; Sharkey RM; Eek A; Joosten L; Oyen WJ; Goldenberg DM; Boerman OC J Nucl Med; 2010 Mar; 51(3):454-61. PubMed ID: 20150268 [TBL] [Abstract][Full Text] [Related]
46. Preclinical evaluation of an Yang X; Liu Z; Zhang H; Li Z; Munasinghe JP; Niu G; Teng G; Chen X Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):585-592. PubMed ID: 29285548 [TBL] [Abstract][Full Text] [Related]
47. Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767 [TBL] [Abstract][Full Text] [Related]
48. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298 [TBL] [Abstract][Full Text] [Related]
49. In Vitro and In Vivo Characterization of an Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329 [TBL] [Abstract][Full Text] [Related]
50. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments. Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306 [TBL] [Abstract][Full Text] [Related]
51. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice. Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and Biologic Evaluation of a Novel Donnelly DJ; Smith RA; Morin P; Lipovšek D; Gokemeijer J; Cohen D; Lafont V; Tran T; Cole EL; Wright M; Kim J; Pena A; Kukral D; Dischino DD; Chow P; Gan J; Adelakun O; Wang XT; Cao K; Leung D; Bonacorsi SJ; Hayes W J Nucl Med; 2018 Mar; 59(3):529-535. PubMed ID: 29025984 [TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide. Hausner SH; Bauer N; Sutcliffe JL Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053 [TBL] [Abstract][Full Text] [Related]
55. Le TM; Lee HR; Abt ER; Rashid K; Creech AL; Liang K; Cui J; Cho A; Wei L; Labora A; Chan C; Sanchez E; Kriti K; Karin D; Li L; Wu N; Mona C; Carlucci G; Hugo W; Wu TT; Donahue TR; Czernin J; Radu CG J Nucl Med; 2023 Jan; 64(1):117-123. PubMed ID: 35738905 [TBL] [Abstract][Full Text] [Related]
56. Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer. Temma T; Nishigori K; Onoe S; Sampei S; Kimura I; Ono M; Saji H Nucl Med Biol; 2015 Feb; 42(2):184-91. PubMed ID: 25457456 [TBL] [Abstract][Full Text] [Related]
57. Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer. Ramos N; Baquero-Buitrago J; Ben Youss Gironda Z; Wadghiri YZ; Reiner T; Boada FE; Carlucci G J Nucl Med; 2020 Mar; 61(3):437-442. PubMed ID: 31481582 [TBL] [Abstract][Full Text] [Related]
58. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET. Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461 [TBL] [Abstract][Full Text] [Related]
59. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1. Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET. Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]